Characterizing trends and associations for hepatitis C virus antibody prevalence in the Middle East and North Africa: meta-regression analyses

[1]  L. Abu-Raddad,et al.  Hepatitis C virus among blood donors and general population in Middle East and North Africa: Meta-analyses and meta-regressions , 2022, World Journal of Meta-Analysis.

[2]  Josephine G. Walker,et al.  Health and economic benefits of achieving hepatitis C virus elimination in Pakistan: A modelling study and economic analysis , 2021, PLoS medicine.

[3]  L. Abu-Raddad,et al.  Characterizing the historical role of parenteral antischistosomal therapy in hepatitis C virus transmission in Egypt , 2020, International journal of epidemiology.

[4]  I. Waked,et al.  Screening and Treatment Program to Eliminate Hepatitis C in Egypt. , 2020, The New England journal of medicine.

[5]  L. Abu-Raddad,et al.  The status of hepatitis C virus infection among people who inject drugs in the Middle East and North Africa , 2020, Addiction.

[6]  J. Higgins,et al.  Cochrane Handbook for Systematic Reviews of Interventions , 2010, International Coaching Psychology Review.

[7]  L. Abu-Raddad,et al.  Characterization of the hepatitis C virus epidemic in Pakistan , 2019, BMC Infectious Diseases.

[8]  N. Low,et al.  Epidemiology of Chlamydia trachomatis in the Middle East and north Africa: a systematic review, meta-analysis, and meta-regression. , 2019, The Lancet. Global health.

[9]  L. Abu-Raddad,et al.  Treatment as prevention for hepatitis C virus in Pakistan: mathematical modelling projections , 2019, BMJ Open.

[10]  L. Abu-Raddad,et al.  Who to Test for Hepatitis C Virus in the Middle East and North Africa?: Pooled Analyses of 2,500 Prevalence Measures, Including 49 Million Tests , 2019, Hepatology communications.

[11]  L. Abu-Raddad,et al.  Hepatitis C virus infection spontaneous clearance: Has it been underestimated? , 2018, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[12]  L. Abu-Raddad,et al.  Individual-level key associations and modes of exposure for hepatitis C virus infection in the Middle East and North Africa: a systematic synthesis. , 2018, Annals of epidemiology.

[13]  L. Abu-Raddad,et al.  Characterizing the temporal evolution of the hepatitis C virus epidemic in Pakistan , 2018, Journal of viral hepatitis.

[14]  L. Abu-Raddad,et al.  The epidemiology of hepatitis C virus in Pakistan: systematic review and meta-analyses , 2018, Royal Society Open Science.

[15]  L. Abu-Raddad,et al.  Characterizing hepatitis C virus epidemiology in Egypt: systematic reviews, meta-analyses, and meta-regressions , 2018, Scientific Reports.

[16]  L. Abu-Raddad,et al.  The epidemiology of hepatitis C virus in Iran: Systematic review and meta-analyses , 2018, Scientific Reports.

[17]  Josephine G. Walker,et al.  Curbing the hepatitis C virus epidemic in Pakistan: the impact of scaling up treatment and prevention for achieving elimination , 2018, International journal of epidemiology.

[18]  L. Abu-Raddad,et al.  Hepatitis C virus viremic rate in the Middle East and North Africa: Systematic synthesis, meta-analyses, and meta-regressions , 2017, PloS one.

[19]  L. Abu-Raddad,et al.  Impact of treatment on hepatitis C virus transmission and incidence in Egypt: A case for treatment as prevention , 2017, Journal of viral hepatitis.

[20]  Reza Assadi,et al.  The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013 , 2016, The Lancet.

[21]  L. Abu-Raddad,et al.  Epidemiology of hepatitis C virus in the Arabian Gulf countries: Systematic review and meta-analysis of prevalence. , 2016, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[22]  L. Abu-Raddad,et al.  Hepatitis C Virus Epidemiology in Djibouti, Somalia, Sudan, and Yemen: Systematic Review and Meta-Analysis , 2016, PloS one.

[23]  L. Abu-Raddad,et al.  Status of HIV and hepatitis C virus infections among prisoners in the Middle East and North Africa: review and synthesis , 2016, Journal of the International AIDS Society.

[24]  S. Holmberg,et al.  Toward a more accurate estimate of the prevalence of hepatitis C in the United States , 2015, Hepatology.

[25]  L. Abu-Raddad,et al.  The epidemiology of hepatitis C virus in Afghanistan: systematic review and meta-analysis. , 2015, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[26]  L. Abu-Raddad,et al.  The Epidemiology of Hepatitis C Virus in the Fertile Crescent: Systematic Review and Meta-Analysis , 2015, PloS one.

[27]  L. Abu-Raddad,et al.  The Epidemiology of Hepatitis C Virus in the Maghreb Region: Systematic Review and Meta-Analyses , 2015, PloS one.

[28]  H. Razavi,et al.  Global epidemiology and genotype distribution of the hepatitis C virus infection. , 2014, Journal of hepatology.

[29]  L. Abu-Raddad,et al.  HIV among People Who Inject Drugs in the Middle East and North Africa: Systematic Review and Data Synthesis , 2014, PLoS medicine.

[30]  M. Daw,et al.  Prevalence of hepatitis B and hepatitis C infection in Libya: results from a national population based survey , 2014, BMC Infectious Diseases.

[31]  L. Abu-Raddad,et al.  The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis , 2013, BMC Infectious Diseases.

[32]  A. Flaxman,et al.  Global epidemiology of hepatitis C virus infection: New estimates of age‐specific antibody to HCV seroprevalence , 2013, Hepatology.

[33]  I. Jacobson,et al.  Advances in the treatment of hepatitis C virus infection. , 2012, Gastroenterology & hepatology.

[34]  D. Lavanchy,et al.  Evolving epidemiology of hepatitis C virus. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[35]  L. Abu-Raddad,et al.  Evidence of intense ongoing endemic transmission of hepatitis C virus in Egypt , 2010, Proceedings of the National Academy of Sciences.

[36]  L. Abu-Raddad,et al.  Epidemiology of HIV infection in the Middle East and North Africa , 2010, AIDS.

[37]  G. Foster,et al.  Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing , 2010, Transfusion.

[38]  David P. Wilson,et al.  Characterizing the HIV/AIDS Epidemic in the Middle East and North Africa: Time for Strategic Action , 2010 .

[39]  D. Moher,et al.  Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement , 2009, BMJ : British Medical Journal.

[40]  Jules L. Dienstag,et al.  An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis , 1989 .

[41]  C. Dolea,et al.  World Health Organization , 1949, International Organization.

[42]  R. Jooma,et al.  Prevalence of hepatitis B and C viral infections in Pakistan: findings of a national survey appealing for effective prevention and control measures. , 2010, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.